Antileukemic activity of aminoparthenolide analogs
- 15 July 2008
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (14), 3870-3873
- https://doi.org/10.1016/j.bmcl.2008.06.050
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetBlood, 2008
- An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cellsBlood, 2007
- (11R)-13-(1-Naphthylmethylamino)-4,5-epoxy-11,13-dihydrocostunolideActa Crystallographica Section E Structure Reports Online, 2007
- (11R)-13-(Benzylamino)-4,5-epoxy-11,13-dihydrocostunolideActa Crystallographica Section E Structure Reports Online, 2007
- Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon systemBioorganic & Medicinal Chemistry, 2006
- The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cellsBlood, 2005
- Antileishmanial Activity of Parthenolide, a Sesquiterpene Lactone Isolated from Tanacetum partheniumAntimicrobial Agents and Chemotherapy, 2005
- Sesquiterpene Lactone Parthenolide Blocks Lipopolysaccharide-Induced Osteolysis Through the Suppression of NF-κB ActivityJournal of Bone and Mineral Research, 2004
- Biosynthesis of Costunolide, Dihydrocostunolide, and Leucodin. Demonstration of Cytochrome P450-Catalyzed Formation of the Lactone Ring Present in Sesquiterpene Lactones of ChicoryPlant Physiology, 2002
- Activity of Parthenolide at 5HT2A ReceptorsJournal of Natural Products, 1997